Diagnostic Significance of Eosinophilic Pleural Effusion
Main Article Content
Abstract
A pleural effusion is defined as eosinophilic when eosinophils represent ≥ 10% of the total nucleated cell count, and accounts for approximately 10% of all pleural effusions. The diagnostic significance of eosinophilic pleural effusion has yet to be determined.
Objective and Methods: A retrospective study was conducted on 65 patients with eosinophilic pleural effusion to evaluate the correlation between the percentage of eosinophils present in the pleural fluid and the benign or malignant nature of the effusion. An original aspect of current study was the evaluation of other variables in association with pleural eosinophilia, in particular pleural fluid lymphocytosis (≥ 50%), and the presence or absence of fever.
Results: Data showed the trend towards a decrease in neoplastic incidence with increasing percentages of eosinophilic counts, although this correlation was not statistically significant. The presence of fever correlated with low incidence of neoplasms (10% of neoplastic effusions in patients with fever) and was the most significant variable (p=0.001), with a Negative Predictive Value of neoplastic disease of 90%, with sensitivity 92.6% and specificity 47.4%.
When evaluated together with fever, eosinophils increased their discriminating sensitivity to the benign or malignant nature of the effusion but lost in specificity.
When evaluated as absence or presence of lymphocytosis (≥50% lymphocytes), associated with eosinophilia, lymphocytes were significantly associated with the neoplastic nature of the effusion.
Conclusions: the study showed that the finding of eosinophilic pleural effusion should not be considered an indicator of benignity of the effusion; the association of other parameters with eosinophilia, lymphocytosis of the pleural fluid and fever can provide more precise prognostic indications; a high percentage of eosinophils, the absence of lymphocytosis and the presence of fever would seem to be associated with a low probability of a neoplastic nature of the effusion.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med. 2003;9:254-260.
3. Adelman M, Albelda SM, Gottlieb J, et al. Diagnostic utility of pleural fluid eosinophilia. Am J Med. 1984;77:915-20.
4. Kuhn M, Fitting JW, Leuenberger P. Probability of malignancy in pleural fluid eosinophilia. Chest. 1989;9:992–994.
5. Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest .1996;110:1271-4.
6. Martinez–Garcia MA, Cases–Viedma E, Cordero–Rodriguez PJ, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J. 2000; 5:166–169.
7. Krenke R, Nasilowski J, Korczynski P, et al. Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J. 2009;34(5):1111-1117.
8. Heidecker J, Kaplan A, Sahn SA.Pleural fluid and peripheral eosinophilia from hemothorax: Hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. Am J Med Sci. 2006; 332:148-52.
9. Kalomenidis I, Light RW. Pathogenesis of the eosinophilic pleural effusions. Curr Opin Pulm Med. 200410(4): 289-93.
10. Nakamura Y, Ozaki T, Kamei T, et al. Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocyte/macrophage colony-stimulating factor, interleukin-5, and interleukin-3. Am J Respir Cell Mol Biol. 1993;8:605-11.
11. Mohamed KH, Abdelhamid AI, Lee YC, et al: Pleural fluid levels of interleukin-5 and eosinophils are closely correlated. Chest. 2002;122:576-580.
12. Ozkara SK, Turan G, Basyigit I. Clinicopathologic significance of eosinophilic pleural effusions in a population with a high prevalence of tuberculosis and cancer. Acta Cytol. 2007;51:773-81.
13. Ferreiro L, San José E, González-Barcala FJ, et al. Eosinophilic pleural effusion: incidence, etiology and prognostic significance. Arch Bronconeumol. 2011;47:504–509.
14. Chu FY, Liou CB, Sun JT, et al. Eosinophilia in Pleural Effusion: a Speculative Negative Predictor for Malignancy. Asian Pac J Cancer Prev. 2016;17(3):1411-4.
15. Oba Y, Abu-Salah T. The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration. 2012;83:198-208.
16. Light RW. Pleural Effusion. N Engl J Med. 2002; 346(25):1971-1977.
17. Krafts KP, Pambuccian SE. Romanowsky staining in cytopathology: history, advantages and limitations. Bio- tech Histochem. 2011;86: 82–93.
18. Archontogeorgis K, Anevlavis S, Zarogoulidis P et al. Pleuroscopy in 'Idiopathic' eosinophilic pleural effusions. Clin Respir J. 2015;9(4):475-80.
19. Antony VB, Godbey SW, Kunkel SL et al. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol. 1993 Dec 15;151(12):7216-23.
20. Valdés L, San José ME, Pose A ,et al. Diagnosing tuberculous pleural effusion using clinical data and pleural fluid analysis A study of patients less than 40 years-old in an area with a high incidence of tuberculosis. Respir Med. 2010 Aug;104(8):1211-7.
21. Wang J, Luo W, Shen P, He J, Zeng Y. Retrospective study of pleural parasitic infestations: a practical diagnostic approach. BMC Infect Dis. 2019 Jul 4;19(1):576.
22. Krenke R, Light RW. Drug-induced eosinophilic pleural effusion. Eur Respir Rev. 2011 Dec;20(122):300-1.
23. Huggins JT, Sahn SA. Drug-induced pleural disease. Clin Chest Med. 2004 Mar;25(1):141-53.
24. Alqalyoobi S, Vaidya O, Al-Ma'Mon Abu Ghanimah, et al. Cocaine Induced Pleural and Pericardial Effusion Syndrome. Case Reports in Pulmonology, 2015; 2015;2015:321539